(Reuters) – Europe’s drugs regulator said on Tuesday it has received an application for the conditional approval of U.S. drugmaker Johnson & Johnson’s COVID-19 vaccine candidate, which is also being assessed by U.S. authorities.
The European Medicines Agency said its human medicines committee (CHMP) will assess the vaccine, known as COVID-19 Vaccine Janssen, under an accelerated timetable. (https://bit.ly/3b9M5SK)
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shounak Dasgupta)
